Evidence map›Paper›PMID 40696076›Full record

ArticleBone marrow transplantation2025

Treatment patterns of extracorporeal photopheresis in steroid-refractory graft versus host disease: A delphi study.

Olaf Penack, Andrea Bacigalupo, Eleni Gavriilaki, Hildegard Greinix, Florent Malard, David Michonneau, Attilio Olivieri, Zinaida Peric, Elisa Sala, Carlos Solano and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olaf PenackCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Augustenburger Platz 1, 13353, Berlin, Germany. olaf.penack@charite.de.ORCID http://orcid.org/0000-0003-4876-802X
Andrea BacigalupoFondazione Policlinico Universitario A. Gemelli, Roma, Italy.
Eleni GavriilakiUniversity of Thessaloniki, Greece; 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-8883-8208
Hildegard GreinixMedizinische Universität Graz, Graz, Austria.
Florent MalardSorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-3474-0002
David MichonneauSaint Louis Hospital, Paris, France.ORCID http://orcid.org/0000-0003-4553-3065
Attilio OlivieriUniversità degli Studi di Ancona, Ancona, Italy.ORCID http://orcid.org/0000-0001-9089-9328
Zinaida PericUniversity Hospital Centre Rijeka, Rijeka, Croatia.
Elisa SalaDepartment of Internal Medicine III, Universitätsklinikum Ulm, Ulm, Germany.
Carlos SolanoHospital Clínico Universitario-INCLIVA, University of Valencia, Valencia, Spain.ORCID http://orcid.org/0000-0003-3702-0817
Daniel WolffDept. of Medicine III, Universitätsklinikum Regensburg, Regensburg, Germany.ORCID http://orcid.org/0000-0001-7015-3190
Robert ZeiserUniversitätsklinikum Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0001-6565-3393

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40696076
PMCPMC12568635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.